387 related articles for article (PubMed ID: 32863957)
1. P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer.
Yao D; Li C; Rajoka MSR; He Z; Huang J; Wang J; Zhang J
Theranostics; 2020; 10(21):9741-9766. PubMed ID: 32863957
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.
Eswaran J; Li DQ; Shah A; Kumar R
Clin Cancer Res; 2012 Jul; 18(14):3743-9. PubMed ID: 22595609
[TBL] [Abstract][Full Text] [Related]
3. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
[TBL] [Abstract][Full Text] [Related]
4. Targeting PAK1 with the Small Molecule Drug AK963/40708899 Suppresses Gastric Cancer Cell Proliferation and Invasion by Downregulation of PAK1 Activity and PAK1-Related Signaling Pathways.
Zhou Y; Zhang J; Wang J; Cheng MS; Zhao DM; Li F
Anat Rec (Hoboken); 2019 Sep; 302(9):1571-1579. PubMed ID: 30773850
[TBL] [Abstract][Full Text] [Related]
5. p21-Activated kinase 1 (PAK1) in aging and longevity: An overview.
Amirthalingam M; Palanisamy S; Tawata S
Ageing Res Rev; 2021 Nov; 71():101443. PubMed ID: 34390849
[TBL] [Abstract][Full Text] [Related]
6. Targeting PAK1.
Semenova G; Chernoff J
Biochem Soc Trans; 2017 Feb; 45(1):79-88. PubMed ID: 28202661
[TBL] [Abstract][Full Text] [Related]
7. PAK4 in cancer development: Emerging player and therapeutic opportunities.
Yuan Y; Zhang H; Li D; Li Y; Lin F; Wang Y; Song H; Liu X; Li F; Zhang J
Cancer Lett; 2022 Oct; 545():215813. PubMed ID: 35798086
[TBL] [Abstract][Full Text] [Related]
8. p21 Activated kinase 1: Nuclear activity and its role during DNA damage repair.
Pérez-Yépez EA; Saldívar-Cerón HI; Villamar-Cruz O; Pérez-Plasencia C; Arias-Romero LE
DNA Repair (Amst); 2018 May; 65():42-46. PubMed ID: 29597073
[TBL] [Abstract][Full Text] [Related]
9. P21 activated kinase signaling in cancer.
Rane CK; Minden A
Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.
Ong CC; Gierke S; Pitt C; Sagolla M; Cheng CK; Zhou W; Jubb AM; Strickland L; Schmidt M; Duron SG; Campbell DA; Zheng W; Dehdashti S; Shen M; Yang N; Behnke ML; Huang W; McKew JC; Chernoff J; Forrest WF; Haverty PM; Chin SF; Rakha EA; Green AR; Ellis IO; Caldas C; O'Brien T; Friedman LS; Koeppen H; Rudolph J; Hoeflich KP
Breast Cancer Res; 2015 Apr; 17(1):59. PubMed ID: 25902869
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest.
Woo TG; Yoon MH; Hong SD; Choi J; Ha NC; Sun H; Park BJ
Oncotarget; 2017 Apr; 8(14):23690-23701. PubMed ID: 28423593
[TBL] [Abstract][Full Text] [Related]
12. Interrogation of kinase genetic interactions provides a global view of PAK1-mediated signal transduction pathways.
Kim JH; Seo Y; Jo M; Jeon H; Kim YS; Kim EJ; Seo D; Lee WH; Kim SR; Yachie N; Zhong Q; Vidal M; Roth FP; Suk K
J Biol Chem; 2020 Dec; 295(50):16906-16919. PubMed ID: 33060198
[TBL] [Abstract][Full Text] [Related]
13. Current trends and opportunities in targeting p21 activated kinase-1(PAK1) for therapeutic management of breast cancers.
Kanumuri R; Saravanan R; Pavithra V; Sundaram S; Rayala SK; Venkatraman G
Gene; 2020 Nov; 760():144991. PubMed ID: 32717309
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells.
Gonzalez N; Cardama GA; Comin MJ; Segatori VI; Pifano M; Alonso DF; Gomez DE; Menna PL
Cell Signal; 2017 Jan; 30():154-161. PubMed ID: 27939839
[TBL] [Abstract][Full Text] [Related]
15. Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells.
Ong CC; Jubb AM; Haverty PM; Zhou W; Tran V; Truong T; Turley H; O'Brien T; Vucic D; Harris AL; Belvin M; Friedman LS; Blackwood EM; Koeppen H; Hoeflich KP
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7177-82. PubMed ID: 21482786
[TBL] [Abstract][Full Text] [Related]
16. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
[TBL] [Abstract][Full Text] [Related]
17. Analysis of small GTPase signaling pathways using p21-activated kinase mutants that selectively couple to Cdc42.
Reeder MK; Serebriiskii IG; Golemis EA; Chernoff J
J Biol Chem; 2001 Nov; 276(44):40606-13. PubMed ID: 11514549
[TBL] [Abstract][Full Text] [Related]
18. P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.
Huynh N; Liu KH; Baldwin GS; He H
Biochim Biophys Acta; 2010 Sep; 1803(9):1106-13. PubMed ID: 20595063
[TBL] [Abstract][Full Text] [Related]
19. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
Parvathy M; Sreeja S; Kumar R; Pillai MR
BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
[TBL] [Abstract][Full Text] [Related]
20. Discovery and characterization of small molecule Rac1 inhibitors.
Arnst JL; Hein AL; Taylor MA; Palermo NY; Contreras JI; Sonawane YA; Wahl AO; Ouellette MM; Natarajan A; Yan Y
Oncotarget; 2017 May; 8(21):34586-34600. PubMed ID: 28410221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
